Skip to content

CoPing strategIes-psyChological flexibiliTy in Patients Hospitalized for Ischemic cardiovascUlaR disEase (PICTURE)

CoPing strategIes-psyChological flexibiliTy in Patients Hospitalized for Ischemic cardiovascUlaR disEase (PICTURE)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05696873
Acronym
PICTURE
Enrollment
80
Registered
2023-01-25
Start date
2023-02-09
Completion date
2025-12-31
Last updated
2024-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Cardiovascular Disease

Keywords

ischemic cardiovascular disease, mental stress, coping strategies, patient's decision to partecipate to clinical trial, adherence to the medications, psychological flexibility, acceptance and commitment therapy, hexaflex, Brief Cope test, MPFI test, CFQ test, MAAS-8 test, CVD-AAQ test

Brief summary

The aim of this trial is to investigate the coping strategies/physiological flexibility construct in patients hospitalized for ischemic cardiovascular disease and the possible association with recurrence of clinical events (any hospitalization and type thereof, myocardial infarction, stroke and death) during the follow up, the patient's decision to participate to clinical trials approved in the center and the adherence to cardiovascular medications.

Interventions

None listed

Sponsors

Cardiocentro Ticino
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years old * Able to provide informed consent * Able to speak and read in the local language spoken in hospital * Admission to the hospital for ischemic cardiovascular disease

Exclusion criteria

* Cannot provide written informed consent * Under judicial protection, tutorship or curatorship * Unable to understand and follow study-related instructions or unable to comply with study protocol * Cognitive impairment * Severe psychiatric disorders according to DSM-5-TR criteria diagnosed in the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
coping strategies and the recurrence of any hospitalization and type thereof, myocardial infarction, stroke and death during the follow up period (2 years±14 days from index hospitalization)2 years (±14 days) from index hospitalizationcoping strategies (evaluated using Brief COPE test) and the recurrence of clinical events (any hospitalization and type thereof, myocardial infarction, stroke and death) during the follow up period (2 years±14 days from index hospitalization)
psychological flexibility and the recurrence any hospitalization and type thereof, myocardial infarction, stroke and death during the follow up period (2 years±14 days from index hospitalization)2 years (±14 days) from index hospitalizationpsychological flexibility construct (evaluated using MPFI test - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the recurrence of clinical events (any hospitalization and type thereof, myocardial infarction, stroke and death) during the follow up period (2 years±14 days from index hospitalization)
coping strategies and the patient's decision to participate to the clinical trials approved in the centresat discharge of index hospitalization (up to 4 weeks)coping strategies (evaluated using Brief COPE test) and the patient's decision to participate to the clinical trials approved in the centres
psychological flexibility and the patient's decision to participate to the clinical trials approved in the centresat discharge of index hospitalization (up to 4 weeks)psychological flexibility construct (evaluated using MPFI test - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the patient's decision to participate to the clinical trials approved in the centres
coping strategies and the adherence to cardiovascular medications2 years (±14 days) from index hospitalizationcoping strategies (evaluated using Brief COPE test) and the adherence to cardiovascular medications
psychological flexibility and the adherence to cardiovascular medications2 years (±14 days) from index hospitalizationpsychological flexibility construct (evaluated using MPFI test and - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the adherence to cardiovascular medications

Secondary

MeasureTime frameDescription
cognitive fusion and adherence to cardiovascular medicationsat 2 years (±14 days) from index hospitalizationcognitive fusion (evaluated using CFQ test - Cognitive Fusion Questionnaire) and adherence to cardiovascular medications
psychological flexibility evaluated with CVD-AAQ test and cardiovascular eventsat 2 years (±14 days) from index hospitalizationpsychological flexibility evaluated with CVD-AAQ test (Cardiovascular Disease Acceptance and Action Questionnaire) and cardiovascular events
each coping strategy and the recurrence of any hospitalization and type thereof, myocardial infarction, stroke and death2 years (±14 days) from index hospitalizationeach coping strategy (evaluated using Brief COPE test) and the recurrence of clinical events type (any hospitalization and type thereof, myocardial infarction, stroke and death)
psychological flexibility evaluated with CVD-AAQ test and adherence to cardiovascular medicationsat 2 years (±14 days) from index hospitalizationpsychological flexibility evaluated with CVD-AAQ test (Cardiovascular Disease Acceptance and Action Questionnaire) and adherence to cardiovascular medications
psychological flexibility evaluated with CVD-AAQ test and participation to the trialsat discharge of index hospitalization (up to 4 weeks)psychological flexibility evaluated with CVD-AAQ test (Cardiovascular Disease Acceptance and Action Questionnaire) and participation to the trials
each component of psychological flexibility model and the recurrence of any hospitalization and type thereof, myocardial infarction, stroke and death2 years (±14 days) from index hospitalizationeach component of psychological flexibility model (evaluated using MPFI test - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the recurrence of clinical events type (any hospitalization and type thereof, myocardial infarction, stroke and death)
each coping strategy (evaluated using Brief COPE test) and the participation to each proposed clinical trial, with a particular focus on the SOS-AMI trialat discharge of index hospitalization (up to 4 weeks)each coping strategy (evaluated using Brief COPE test) and the participation to each proposed clinical trial, with a particular focus on the SOS-AMI trial, since it requires copying with the patient decision to self-administer treatment unlike other studies in which treatment is physician-directed
each component of psychological flexibility and the participation to each proposed clinical trial, with a particular focus on the SOS-AMI trialat discharge of index hospitalization (up to 4 weeks)each component of psychological flexibility construct (evaluated using MPFI test and - Multidimensional Psychological Flexibility Inventory test and CFQ test - Cognitive Fusion Questionnaire) and the participation to each proposed clinical trial, with a particular focus on the SOS-AMI trial, since it requires copying with the patient decision to self-administer treatment unlike other studies in which treatment is physician-directed
cognitive fusion and recurrence of cardiovascular eventsat 2 years (±14 days) from index hospitalizationcognitive fusion (evaluated using CFQ test - Cognitive Fusion Questionnaire) and recurrence of cardiovascular events
cognitive fusion and participation to the trialsat discharge of index hospitalization (up to 4 weeks)cognitive fusion (evaluated using CFQ test - Cognitive Fusion Questionnaire) and participation to the trials

Countries

Switzerland

Contacts

Primary ContactMarco Valgimigli, M.D., Ph.D
marco.valgimigli@eoc.ch+410918115111
Backup Contactenrico frigoli, M.D.
enricofrigoli@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026